Providence Wealth Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$13.7K	Buy	15,000 +2,500	+20%	+$2.28K	0.01%	84
2025 Q1	$9.96K	Hold	12,500	–	–	0.01%	82
2024 Q4	$21K	Buy	12,500 +2,500	+25%	+$4.2K	0.02%	79
2024 Q3	$8.31K	Buy	+10,000	New	+$8.31K	0.01%	81